[EN] USE OF LRRK2 INHIBITORS FOR NEURODEGENERATIVE DISEASES<br/>[FR] UTILISATION D'INHIBITEURS DE LRRK2 POUR MALADIES NEURODÉGÉNÉRATIVES
申请人:CELLZOME LTD
公开号:WO2009127642A2
公开(公告)日:2009-10-22
The invention relates to compounds of formula (I), wherein R1 to R9 and R4a have the meaning as cited in the description and the claims for use in a for use in a method of treating or preventing diseases and disorders associated with LRRK2. Said compounds are useful as inhibitors of LRRK2 for the treatment or prophylaxis of neurodegenerative diseases, like Parkinson's disease or Alzheimer's disease. The invention also relates to the preparation of such compounds.